Advertisement
Editorial: Want to fight chronic disease? Stop subsidizing drug companies

Editorial: Want to fight chronic disease? Stop subsidizing drug companies

By Merrill Goozner  |  May 13, 2017

Healthcare systems have come a long way using their medical records and claims data to flag patients at high risk of contracting chronic diseases such as diabetes. Unfortunately, under fee-for-service medicine, doing something with that information is rarely a smart move financially.

Editorial: End the slow-walk on payment reform

Editorial: End the slow-walk on payment reform

By Merrill Goozner  |  May 06, 2017

Payment reform won't change the graying of America. But it is exactly what the doctor ordered to deal with the outrageously high prices and overutilization of questionable technologies that plague the entire system.

Editorial: The phony war on high drug prices

Editorial: The phony war on high drug prices

By Merrill Goozner  |  April 27, 2017

Politics, like nature, abhors a vacuum. Witness how the pharmaceutical industry has succeeded in taking advantage of President Donald Trump's failure to do something—anything—about high drug prices.

Our Code of Ethics

By Aurora Aguilar  |  April 22, 2017

Our Editorial Code of Ethics, which is regularly updated and also can be found under the "About Us" section of ModernHealthcare.com, offers the parameters under which we work.

Editorial: Which Scott Gottlieb will run the FDA?

Editorial: Which Scott Gottlieb will run the FDA?

By Merrill Goozner  |  April 08, 2017

Dr. Scott Gottlieb is by far the most conflicted person nominated to run the 111-year-old Food and Drug Administration. If the Office of Government Ethics was doing its job, it wouldn't let him near the commissioner's chair for at least a year.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print